{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:56:45Z","timestamp":1789016205174,"version":"build-2803163510"},"reference-count":41,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.bbmt.2019.07.011","type":"journal-article","created":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T19:26:07Z","timestamp":1563218767000},"page":"2197-2210","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Transplantation in Children and Adolescents with Acute Lymphoblastic Leukemia from a Matched Donor versus an HLA-Identical Sibling: Is the Outcome Comparable? Results from the International BFM ALL SCT 2007 Study"],"prefix":"10.1016","volume":"25","author":[{"given":"Adriana","family":"Balduzzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Hugues","family":"Dalle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Wachowiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Yaniv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akif","family":"Yesilipek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Sedlacek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Bierings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Ifversen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina","family":"Sufliarska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Kalwak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjan","family":"Lankester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6012-0651","authenticated-orcid":false,"given":"Jacek","family":"Toporski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Di Maio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgenia","family":"Glogova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Poetschger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2019.07.011_bib0001","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1182\/blood-2013-10-532598","article-title":"Childhood high-risk acute lymphoblastic leukemia in first remission: results after chemotherapy or transplant from the AIEOP ALL 2000 study","volume":"123","author":"Conter","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.07.011_bib0002","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1182\/blood-2011-03-338707","article-title":"Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study","volume":"118","author":"Schrappe","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.07.011_bib0003","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1200\/JCO.2011.37.8018","article-title":"Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the Children's Oncology Group","volume":"30","author":"Hunger","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2019.07.011_bib0004","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1182\/blood-2012-05-378943","article-title":"Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?","volume":"120","author":"Pui","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.07.011_bib0005","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1182\/blood-2009-10-248146","article-title":"Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study","volume":"115","author":"Conter","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.07.011_bib0006","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(05)66998-X","article-title":"Chemotherapy versus allogeneic transplantation for very-high-risk childhood acute lymphoblastic leukaemia in first complete remission: comparison by genetic randomisation in an international prospective study","volume":"366","author":"Balduzzi","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.bbmt.2019.07.011_bib0007","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1200\/JCO.2014.58.9747","article-title":"Stem-cell transplantation in children with acute lymphoblastic leukemia: a prospective international multicenter trial comparing sibling donors with matched unrelated donors\u2013the ALL-SCT-BFM-2003 trial","volume":"33","author":"Peters","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2019.07.011_bib0008","series-title":"Allogeneic Stem Cell Transplantation","first-page":"219","article-title":"Allogeneic hematopoietic stem cell transplantation in pediatric acute lymphoblastic leukemia","author":"Balduzzi","year":"2010"},{"issue":"suppl 1","key":"10.1016\/j.bbmt.2019.07.011_bib0009","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1038\/sj.bmt.1704835","article-title":"Allogeneic haematopoietic stem cell transplantation in children with acute lymphoblastic leukaemia: the BFM\/IBFM\/EBMT concepts","volume":"35","author":"Peters","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.07.011_bib0010","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1182\/blood-2013-05-355982","article-title":"The major histocompatibility complex: a model for understanding graft-versus-host disease","volume":"122","author":"Petersdorf","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.07.011_bib0011","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/j.bbmt.2018.05.009","article-title":"Allogeneic stem cell transplantation from HLA-mismatched donors for pediatric patients with acute lymphoblastic leukemia treated according to the 2003 BFM and 2007 International-BFM studies: impact of disease risk on outcomes","volume":"24","author":"Dalle","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.07.011_bib0012","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1182\/blood-2010-03-273532","article-title":"Improved outcome with hematopoietic stem cell transplantation in a poor prognostic subgroup of infants with mixed-lineage-leukemia (MLL)-rearranged acute lymphoblastic leukemia: results from the Interfant-99 Study","volume":"116","author":"Mann","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.07.011_bib0013","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1182\/blood-2004-05-1944","article-title":"Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS\/EBMT trial","volume":"105","author":"Locatelli","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.07.011_bib0014","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1053\/j.seminhematol.2005.09.003","article-title":"The clinical spectrum of acute graft-versus-host disease","volume":"43","author":"Deeg","year":"2006","journal-title":"Semin Hematol"},{"key":"10.1016\/j.bbmt.2019.07.011_bib0015","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report","volume":"11","author":"Filipovich","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.07.011_bib0016","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/bjh.12639","article-title":"Minimal residual disease before and after transplantation for childhood acute lymphoblastic leukaemia: is there any room for intervention?","volume":"164","author":"Balduzzi","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2019.07.011_bib0017","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1200\/JCO.2008.17.6065","article-title":"Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM Study Group","volume":"27","author":"Bader","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2019.07.011_bib0018","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/bjh.13142","article-title":"Persistent MRD before and after allogeneic BMT predicts relapse in children with acute lymphoblastic leukaemia","volume":"168","author":"Sutton","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2019.07.011_bib0019","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/bmt.2015.103","article-title":"Risk factors and timing of relapse after allogeneic transplantation in pediatric ALL: for whom and when should interventions be tested?","volume":"50","author":"Pulsipher","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.07.011_bib0020","doi-asserted-by":"crossref","first-page":"541","DOI":"10.2307\/2530374","article-title":"The analysis of failure times in the presence of competing risks","volume":"34","author":"Prentice","year":"1978","journal-title":"Biometrics"},{"key":"10.1016\/j.bbmt.2019.07.011_bib0021","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1214\/aos\/1176350951","article-title":"A class of K-sample tests for comparing the cumulative incidence of a competing risk","volume":"16","author":"Gray","year":"1988","journal-title":"Ann Stat"},{"key":"10.1016\/j.bbmt.2019.07.011_bib0022","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.bbmt.2019.07.011_bib0023","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.bbmt.2015.01.011","article-title":"Reevaluation of the pretransplant assessment of mortality score after allogeneic hematopoietic transplantation","volume":"21","author":"Au","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.07.011_bib0024","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.bbmt.2008.02.018","article-title":"Excellent outcome of allogeneic hematopoietic stem cell transplantation using a conditioning regimen with medium-dose VP-16, cyclophosphamide and total-body irradiation for adult patients with acute lymphoblastic leukemia","volume":"14","author":"Shigematsu","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.07.011_bib0025","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/bmt.2017.66","volume":"52","author":"Simonin","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.07.011_bib0026","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1182\/blood-2011-04-349688","article-title":"Risk of complications during hematopoietic stem cell collection in pediatric sibling donors: a prospective European Group for Blood and Marrow Transplantation Pediatric Diseases Working Party study","volume":"119","author":"Styczynski","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.07.011_bib0027","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1182\/blood-2013-10-534297","article-title":"The addition of sirolimus to tacrolimus\/methotrexate GVHD prophylaxis in children with ALL: a phase 3 Children's Oncology Group\/Pediatric Blood and Marrow Transplant Consortium trial","volume":"123","author":"Pulsipher","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.07.011_bib0028","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.bbmt.2012.01.007","article-title":"Comparison of outcomes after HLA-matched sibling and unrelated donor transplantation for children with high-risk acute lymphoblastic leukemia","volume":"18","author":"Zhang","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.07.011_bib0029","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1182\/blood.V95.5.1572.005k12_1572_1579","article-title":"Graft versus host disease prophylaxis with low-dose cyclosporine-A reduces the risk of relapse in children with acute leukemia given HLA-identical sibling bone marrow transplantation: results of a randomized trial","volume":"95","author":"Locatelli","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.07.011_bib0030","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26726","article-title":"Outcomes of matched sibling donor bone marrow transplantation in children using single-agent calcineurin inhibitors as prophylaxis for graft versus host disease","volume":"65","author":"Elgarten","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.bbmt.2019.07.011_bib0031","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00432-014-1885-y","article-title":"Superior outcome using cyclosporin A alone versus cyclosporin A plus methotrexate for post-transplant immunosuppression in children with acute leukemia undergoing sibling hematopoietic stem cell transplantation","volume":"141","author":"Weiss","year":"2015","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.bbmt.2019.07.011_bib0032","doi-asserted-by":"crossref","first-page":"6683","DOI":"10.1182\/blood-2011-05-354233","article-title":"No difference in outcome between children and adolescents transplanted for acute lymphoblastic leukemia in second remission","volume":"118","author":"Dini","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.07.011_bib0033","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1056\/NEJMoa1203517","article-title":"Peripheral-blood stem cells versus bone marrow from unrelated donors","volume":"367","author":"Anasetti","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2019.07.011_bib0034","doi-asserted-by":"crossref","first-page":"4872","DOI":"10.1200\/JCO.2004.02.189","article-title":"Higher mortality after allogeneic peripheral-blood transplantation compared with bone marrow in children and adolescents: the Histocompatibility and Alternate Stem Cell Source Working Committee of the International Bone Marrow Transplant Registry","volume":"22","author":"Eapen","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2019.07.011_bib0035","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1056\/NEJMoa1506002","article-title":"Antilymphocyte globulin for prevention of chronic graft-versus-host disease","volume":"374","author":"Kr\u00f6ger","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2019.07.011_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbmt.2019.04.014","article-title":"Allogeneic stem cell transplantation for acute lymphoblastic leukemia in adolescents and young adults","author":"Hangai","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.07.011_bib0037","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/pbc.25333","article-title":"Hematopoietic stem cell transplantation in infants","volume":"62","author":"Gassas","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.bbmt.2019.07.011_bib0038","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.bbmt.2015.09.006","article-title":"Effect of cytomegalovirus reactivation on relapse after allogeneic hematopoietic stem cell transplantation in pediatric acute leukemia","volume":"22","author":"Inagaki","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.07.011_bib0039","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1182\/blood-2014-10-604702","article-title":"Comparison of transplantation with reduced and myeloablative conditioning for children with acute lymphoblastic leukemia","volume":"125","author":"Kato","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.07.011_bib0040","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1002\/pbc.25602","article-title":"Comparison of chemotherapeutic agents as a myeloablative conditioning with total body irradiation for pediatric acute lymphoblastic leukemia: a study from the pediatric ALL working group of the Japan Society for Hematopoietic Cell Transplantation","volume":"62","author":"Kato","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.bbmt.2019.07.011_bib0041","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/leu.2014.203","article-title":"Second cancers and late mortality in Australian children treated by allogeneic HSCT for haematological malignancy","volume":"29","author":"Nelson","year":"2015","journal-title":"Leukemia"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879119304434?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879119304434?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:07:27Z","timestamp":1761059247000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879119304434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":41,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S1083879119304434"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2019.07.011","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transplantation in Children and Adolescents with Acute Lymphoblastic Leukemia from a Matched Donor versus an HLA-Identical Sibling: Is the Outcome Comparable? Results from the International BFM ALL SCT 2007 Study","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2019.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}